The forecasted data for antiretroviral therapy coverage in France shows a gradual increase from 87% in 2024 to 90% in 2028 for adult women living with HIV. In 2023, coverage was at 86%. Year-on-year increases are consistently around 1% until 2026, maintaining the same level in 2027, before rising again by 1% in 2028. The compound annual growth rate (CAGR) for the past five years stands at approximately 1.14%.
Future trends to watch for include potential policy changes, technological advancements in treatment, and increased awareness and testing, possibly accelerating coverage improvements. Additionally, monitoring economic factors and healthcare infrastructure investments will be crucial in assessing sustainable coverage growth.
